Doksiciklīna hiklāts, Doksiciklīna HCL EP / BP

Produkts	Doksiciklīna hiklāts
CAS	2058-46-0
Ķīmiskais nosaukums:	4S (4aR, 5S, 5aR, 6R, 12aS)] - 4- (dimetilamino) -1,4,4a, 5,5a, 6,11,12a-oktahidro-3,5,10,12,12a-pentahidroksi- 6-metil-1,11-dezoksonaftacēn-2-karboksamīda monohidrohlorīds, savienojums ar etilspirtu (2: 1 )
Molekulārā formula	C 22H 24N 2O 8· HCL · 1 / 2C 2H 5OH · 1 / 2H 2O
Molekulārais svars	24390-14-5
Iepakojums	Eksportēt cienīgu iepakojumu
Materiālu drošības datu lapa	Pieejams pēc pieprasījuma
Komentāri	tetraciklīna antibiotiku grupa

Doksicilīna hidrohlorīds
Doksiciklīna hiklāts ir sintētisks tetraciklīna atvasinājums ar līdzīgu pretmikrobu iedarbību.
 
Drug Indication 
1)Treatment of periodontal disease in dogs
 
2)Pigs: clinical signs with porcine respiratory disease. Chickens: to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis. Also in respiratory infections caused by Ornithobacterium rhinotracheale.
 
3)Treatment of infections of the respiratory tract and alimentary tract caused by micro-organisms susceptible to doxycycline.
 
4)Chickens: to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis caused by Pasteurella multocida or to reduce morbidity and lesions in respiratory infections caused by Ornithobacterium rhinotracheale (ORT)
 
5)Treatment of systemic amyloidosis caused by beta-2 microglobulin
 
6)Treatment of familial amyloid polyneuropathy